Remove Big Data Remove Bioinformatics Remove Clinical Trials Remove Gene
article thumbnail

UK research partners team up to accelerate MND drug discovery

Drug Discovery World

Identifying genes linked with MND A key part of the MND Translational Challenge therapeutic strategy is to validate and de-risk MND targets using human genetic evidence. The proposed programme uses bioinformatics approaches and experimental models to validate and de-risk a portfolio of potential MND therapeutic targets.

article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

For example, Sanofi, Pfizer, Gilead, Novartis, BMS, Genentech, and Bayer have all announced significant alliances to integrate these big data technologies into drug discovery operations. Clinical Decision Support Software, Guidance for Industry and Food and Drug Administration Staff Document issued on September 28, 2022.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.